Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/13/13 → 12/31/15 |
An Open-Label Treatment Use Protocol for Ibrutinib (PCI-32765) in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
- Hayslip, John (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 7/13/13 → 12/31/15 |